Sign-up for our newsletter

Funding Program Application Invoice

Welcome to the 看片视频 Funding Program Application Invoice Summary Page.

Application	Evaluating the efficacy of MSI-1436 in slowing the progression and in reversing diabetic nephropathy in the BTBR ob/ob mouse (Yin, Viravuth)
Institution	Novo Biosciences
ExternalID	32307-29
Invoice Date	9/14/2020
Date Received	9/15/2020
Start Date	7/1/2020
End Date	8/31/2020
Direct Costs Funds Available	$0.02
Direct Total	$24,725.01
Indirect Total	$0.00
Direct + Indirect	$24,725.01
Uploaded Invoice	View Invoice Document